- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 498/12 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 498/12
Total number of patents in this class: 74
10-year publication summary
8
|
3
|
2
|
5
|
4
|
5
|
4
|
6
|
8
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
S*BIO Pte Ltd. | 28 |
4 |
F. Hoffmann-La Roche AG | 7958 |
3 |
Salix Pharmaceuticals, Ltd. | 48 |
3 |
Bristol-myers Squibb Company | 5080 |
2 |
Hoffmann-La Roche Inc. | 3060 |
2 |
The Regents of the University of Michigan | 4409 |
2 |
Actelion Pharmaceuticals Ltd | 576 |
2 |
Azad Pharma AG | 23 |
2 |
CTI Biopharma Corp. | 56 |
2 |
Indena S.p.A. | 661 |
2 |
Lupin Limited | 448 |
2 |
Revolution Medicines, Inc. | 153 |
2 |
Salix Pharmaceuticals, Inc. | 90 |
2 |
Tiumbio Co., Ltd. | 21 |
2 |
Fochon Biosciences, Ltd. | 26 |
2 |
Samsung Display Co., Ltd. | 30585 |
1 |
Genentech, Inc. | 3742 |
1 |
Merck Sharp & Dohme Corp. | 2247 |
1 |
Syngenta Participations AG | 4970 |
1 |
Coley Pharmaceutical Group, Inc. | 59 |
1 |
Other owners | 35 |